The Blood Jobs and more

theblood: Revolutionizing Women's Health through Menstrual Blood Analysis

Key Products and Services

The startup theblood, founded by Isabelle Guenou and Miriam Santer, focuses on the development and application of menstrual blood analysis methods to improve women's health. The company offers a non-invasive menstrual blood test kit that allows women to access, understand, and benefit from their individual health data. These analyses include the measurement of hormone levels, proteins, vitamins, and other biomarkers that provide valuable insights into hormonal changes, inflammation, and other important health indicators[2][4].

Main Mission and Values

edit

The main mission of theblood is to close the Gender Data Gap by providing women access to their individual health data and enabling them to understand it. The company aims to promote self-determination and control over cycle-related health conditions, thereby improving the diagnosis and treatment of women's health issues. Isabelle Guenou and Miriam Santer, both with personal experiences in lengthy and often inadequate medical diagnosis processes, passionately and ambitiously drive this mission forward[1][3].

Sustainability Goals and Initiatives

edit

theblood is committed to sustainably improving women's health and is working to close existing research gaps in the area of menstruation. By analyzing menstrual blood, earlier and more accurate diagnoses of conditions such as endometriosis, PCOS, early menopause, and hormonal imbalances are to be enabled. The company emphasizes the importance of data-driven insights to enhance women's quality of life and optimize healthcare[1][4].

Current Developments and Partnerships

edit

theblood has recently entered into a partnership with Rox Health, a subsidiary of the pharmaceutical company Roche, which supports the further expansion of their research and development. The company is also listed in Forbes 30 Under 30 and won 1st place in the Diversity category at the Tech Award Gala by WLOUNGE, recognizing their innovative work and commitment[1][2].

Future Orientation

edit

The menstrual blood test is planned to be launched next summer after a feasibility study was conducted at the University of Rostock. To approve the product as a medical device, further medical studies will be conducted. theblood remains optimistic and committed to the further development of their technology and services to provide better health opportunities for women worldwide[2].

Sources:

edit